Back
X4 Pharmaceuticals Vs. Tandem Diabetes Care Industry Stock Comparison
Sell
48
XFOR
X4 Pharmaceuticals
Last Price:
0.98
Seasonality Move:
-29.63%
Sell
46
TNDM
Tandem Diabetes Care
Last Price:
43.23
Seasonality Move:
20.45%
Sell
48
X4 Pharmaceuticals (XFOR)
is a Sell
Is X4 Pharmaceuticals a Buy, Sell or Hold?
- The current X4 Pharmaceuticals [XFOR] share price is $1.02. The Score for XFOR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- XFOR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Tandem Diabetes Care (TNDM)
is a Sell
Is Tandem Diabetes Care a Buy, Sell or Hold?
- The current Tandem Diabetes Care [TNDM] share price is $45.33. The Score for TNDM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- TNDM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XFOR Stock Price Chart
What is X4 Pharmaceuticals's stock price today?
-
The X4 Pharmaceuticals share price today is $1.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XFOR is experiencing slight buying pressure.
TNDM Stock Price Chart
What is Tandem Diabetes Care's stock price today?
-
The Tandem Diabetes Care share price today is $45.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TNDM is experiencing buying pressure, which is a positive indicator for future bullish movement.
XFOR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 48.44 | Sell |
| Chaikin Money Flow: | 492075 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.93 - 1.05) | Buy |
| Bollinger Bands (100): | (0.86 - 1.24) | Sell |
TNDM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 44.36 | Sell |
| Chaikin Money Flow: | 864407 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.03 - 51.67) | Sell |
| Bollinger Bands (100): | (25.46 - 44.48) | Buy |
XFOR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.05 | Sell |
| 20-day SMA: | 0.99 | Buy |
| 50-day SMA: | 1.1 | Sell |
| 200-day SMA: | 0.97 | Buy |
| 8-day EMA: | 1.04 | Sell |
| 20-day EMA: | 1.03 | Sell |
| 50-day EMA: | 1.05 | Sell |
| 200-day EMA: | 1.08 | Sell |
TNDM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.18 | Sell |
| 20-day SMA: | 49.73 | Sell |
| 50-day SMA: | 42.42 | Buy |
| 200-day SMA: | 28.56 | Buy |
| 8-day EMA: | 47.67 | Sell |
| 20-day EMA: | 47.9 | Sell |
| 50-day EMA: | 43.47 | Buy |
| 200-day EMA: | 34.22 | Buy |
X4 Pharmaceuticals Earnings Growth & XFOR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.01 per share, an increase this year of $0.10 per share, and an increase next year of $0.05 per share.
Tandem Diabetes Care Earnings Growth & TNDM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.14 per share, and an increase next year of $0.55 per share.
X4 Pharmaceuticals Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tandem Diabetes Care Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||